demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID 19 all comersCOVID-19 mild to moderate
COVID 19 hospitalizedCOVID 19 all comersCOVID-19 mild to moderate
Renin-angiotensin-system-acting agents
angiotensin receptor blockers (ARBs) Nouri-Vaskeh
losartan University of Minnesota
discontinuation of ACEI/ARB Lopes ...

12 studies excluded by filtering options 0

5092 Yang, 2020 1133not a RCThigh risk of bias
5228 Bean, 2020 1193not a RCThigh risk of bias
5295 Zhang, 2020 1133not a RCThigh risk of bias
5331 Li, 2020 1134not a RCThigh risk of bias
5332 Meng, 2020 1134not a RCThigh risk of bias
5345 Yan et al., 2020 1204not a RCThigh risk of bias
5347 Mehra, 2020 2124excludednot a RCThigh risk of bias
5595 Duarte, 2020 113high risk of bias
6139 Dublin, 2020 0120selection pending
6139 Dublin, 2020 0120selection pending
6479 REPLACE, 2020 110risk of bias not avaialble
8142 Najmeddin, 2021 010selection pending